Upload
kelsey-preston
View
39
Download
4
Embed Size (px)
DESCRIPTION
Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level. Hsu CY et al. Arch Intern Med 2005; 165:923-928. - PowerPoint PPT Presentation
Citation preview
Hsu CY et al. Arch Intern Med 2005;165:923-928.
BP level (mm Hg)Adjusted relative risk 95% CI
<120/80 Reference —
120-129/80-84 1.62 1.27-2.07
130-139/85-89 1.98 1.55-2.52
140-159/90-99 2.59 2.07-3.25
160-179/100-109 3.86 3.00-4.96
180-209/110-119 3.88 2.82-5.34
>210/120 4.25 2.63-6.86
Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level
Relative risk for incidence of ESRD with amlodipine and lisinopril vs diuretic in patients with mild or moderate to severe reductions in GFR at baseline
Rahman M et al. Arch Intern Med 2005;165:923-928.
Treatment group Relative risk 95% CI
Diuretics Reference —
Amlodipine
•Mild reduction in GFR 1.47 0.97-2.23
•Moderate to severe reduction in GFR
0.92 0.68-1.24
Lisinopril
•Mild GFR reduction 1.34 0.87-2.06
•Moderate to severe reduction in GFR
0.98 0.73-1.31